Neurocrine Biosciences earnings

Next report

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 28, 2025 and Oct 30, 2024, after the close.

Who else reports that week: the earnings calendar.

Last report: Jul 30, 2026, 20:02 ET (after the close). The filing on SEC EDGAR ↗

Across the last 4 reports we hold closes for, the first close moved a median 9.47% either way. Up 1 of 4.

Moves are only shown for reports where we hold closing prices.

1. Jul 30, 202620:02 ET · after the close8-K ↗−10.08%1DRevenue $959.0M+39.5% y/yEPS $1.39quarter to Jun 30, 2026
2. May 5, 202620:02 ET · after the close8-K ↗+8.86%1DRevenue $814.5M+42.2% y/yEPS $1.91quarter to Mar 31, 2026
3. Feb 11, 202621:02 ET · after the close8-K ↗−10.43%1DRevenue $805.5M+28.3% y/yquarter to Dec 31, 2025
4. Oct 28, 202520:02 ET · after the close8-K ↗−6.35%1DRevenue $794.9M+27.8% y/yEPS $2.04quarter to Sep 30, 2025
5. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
6. Jul 30, 202520:02 ET · after the close8-K ↗Revenue $687.5M+16.5% y/yEPS $1.06quarter to Jun 30, 2025
7. May 5, 202520:02 ET · after the close8-K ↗Revenue $572.6M+11.1% y/yEPS $0.08quarter to Mar 31, 2025
8. Feb 6, 202521:04 ET · after the close8-K ↗Revenue $627.7M+21.8% y/yquarter to Dec 31, 2024
9. Oct 30, 202411:02 ET · during the session8-K ↗Revenue $622.1M+24.7% y/yEPS $1.24quarter to Sep 30, 2024
10. Aug 1, 202411:03 ET · during the session8-K ↗Revenue $590.2M+30.4% y/yEPS $0.63quarter to Jun 30, 2024
11. May 1, 202411:01 ET · during the session8-K ↗Revenue $515.3M+22.6% y/yEPS $0.42quarter to Mar 31, 2024
12. Feb 7, 202412:00 ET · during the session8-K ↗Revenue $515.2M+25.0% y/yquarter to Dec 31, 2023
13. Oct 31, 202311:01 ET · during the session8-K ↗Revenue $498.8M+28.6% y/yEPS $0.82quarter to Sep 30, 2023
14. Aug 1, 202311:02 ET · during the session8-K ↗Revenue $452.7M+19.7% y/yEPS $0.95quarter to Jun 30, 2023
15. May 3, 202311:32 ET · during the session8-K ↗Revenue $420.4M+35.4% y/yEPS −$0.79quarter to Mar 31, 2023
16. Feb 6, 202312:32 ET · during the session8-K ↗Revenue $412.0M+32.1% y/yquarter to Dec 31, 2022
17. Nov 1, 202211:31 ET · during the session8-K ↗Revenue $387.9M+31.0% y/yEPS $0.69quarter to Sep 30, 2022

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. Prior-session closes only; not a forecast, not advice.